Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium.

Emerging infectious diseases - 1 May 2017

Murray Gerald L, Bradshaw Catriona S, Bissessor Melanie, Danielewski Jennifer, Garland Suzanne M, Jensen Jørgen S, Fairley Christopher K, Tabrizi Sepehr N

Abstract excerpt

Escalating resistance to azithromycin and moxifloxacin is being reported for Mycoplasma genitalium in the Asia-Pacific region. Analyzing 140 infections, we found pretreatment fluoroquinolone-resistance mutations in parC (13.6%) and gyrA (5%). ParC S83 changes were associated with moxifloxacin failure. Combined macrolide/fluoroquinolone-resistance mutations were in 8.6% of specimens, for which recommended...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Australia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Fluoroquinolones

Share to Genes, Bacterial

Share to Macrolides

Share to Mycoplasma genitalium

Share to Mycoplasma Infections

Source

Open in PubMed Open full text

Identifiers

PMID: 28418319
DOI: 10.3201/eid2305.161745
PMCID: PMC5403035

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium.PMID 28418319Read ↗

Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.Semantic proximity Read ↗

Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan.Semantic proximity Read ↗

Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistanceSemantic proximity Read ↗

Multidrug-resistant Mycoplasma genitalium infections in Europe.Semantic proximity Read ↗

Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.Semantic proximity Read ↗

gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy.Semantic proximity Read ↗

Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.Semantic proximity Read ↗

Emerging multidrug resistance contributes to treatment failure in Mycoplasma genitalium infected patients in China.Semantic proximity Read ↗

Detection of markers predictive of macrolide and fluoroquinolone resistance in Mycoplasma genitalium from patients attending sexual health services.Semantic proximity Read ↗

Detection of macrolide and fluoroquinolone resistance-associated 23S rRNA and parC mutations in Mycoplasma genitalium by nested real-time PCR.Semantic proximity Read ↗

Mycoplasma genitalium infections can comprise a mixture of both fluoroquinolone-susceptible and fluoroquinolone-resistant strains.Semantic proximity Read ↗

parC Variants in Mycoplasma genitalium: Trends over Time and Association with Moxifloxacin FailureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.